Daniel Teschner

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Drew J. Winston, Kathleen M. Mullane, Oliver A. Cornely et al. · The Lancet · 2018 · 93 citations

Vaccination, Transplantation, Marrow Transplantation +8

Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis

Daniel Teschner, E. Distler, Daniela Wehler et al. · Bone Marrow Transplantation · 2013 · 92 citations

Cell Therapy, Naive T Cells, Gvhd Prophylaxis +10

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Markus Ruhnke, Oliver A. Cornely, Martin Schmidt‐Hieber et al. · Mycoses · 2020 · 70 citations · Full text

Influenza virus infections in patients with malignancies –– characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)

Beate Hermann, Nicola Lehners, Michael Brodhun et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2016 · 46 citations · Full text

Vaccination, Infectious Disease Epidemiology, Influenza Virus Infections +14